Navigation Links
Micromet Closes $40 Million Private Equity Placement
Date:10/3/2008

development. In addition, Micromet has established a collaboration with Nycomed for the development and commercialization of MT203, a human antibody neutralizing the activity of granulocyte/macrophage colony stimulating factor (GM-CSF), which has potential applications in the treatment of various inflammatory and autoimmune diseases, such as rheumatoid arthritis, psoriasis, or multiple sclerosis.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the application of the funds received in the private placement, the efficacy, safety and intended utilization of our product candidates, the development of our BiTE antibody technology, the conduct, timing and results of future clinical trials, expectations of the future expansion of our product pipeline and collaborations, and our plans regarding future presentations of clinical data. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do not demonstrate safety and/or efficacy in subsequent clinical trials, the risk that encouraging results from early research, preclinical studies or clinical trials may not be confirmed upon further analysis of the detailed results of such research, preclinical study or clinical trial, the risk that additional information relating to
'/>"/>

SOURCE Micromet, Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... GlobalStemCellsGroup.com has recruited Mario Camacho ... biomedical researcher and founding partner of Criogenix SA de ... biomedical professors who will teach the “Diplomat in Cell ... CV is a private company registered in the National ... Mexico (RENIECYT). , Camacho Alcocer will teach two-day, interactive ...
(Date:3/2/2015)... March 02, 2015 Resilinc ... annual report which summarizes and analyzes nearly 700 ... EventWatch™ 24X7 global event monitoring and alert ... to a free trial period of the email service ... incidents that can negatively impact revenue, market share, customer ...
(Date:3/2/2015)... , March 2, 2015 ... healthy whole food nutrition products reveal technological advancements ... related disorders such as hyperglycemia, obesity, insulin level ... Nutraceutical and Biotech Companies in focus today are: RiceBran ... Foods Ltd. (NYSE: ANFI ), CEL-SCI ...
(Date:3/2/2015)... 02, 2015 Global Stem ... alliance with Shenzhen HANK Bioengineering Co., Ltd. and ... alliance will establish a stem cells training course ... in September 2015. , Shenzhen HANK is a ... award-winning scientist, microbiologist and virologist, to integrate research, ...
Breaking Biology Technology:Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 2Mario Camacho Alcocer Joins Global Stem Cells Group Faculty 3Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 2Resilinc Publishes 2014 EventWatch™ Supply Chain Disruption Annual Report 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3
... , , , ... ), a biopharmaceutical company dedicated to improving patient care by developing novel ... and program highlights for the second quarter ended June 30, 2009. ... structure and Phase II protocol allowance from the FDA, we are well ...
... ... ... 30, 2009 -- IntertechPira has teamed up with Carbonfund.org to create a zero-carbon event. ... offsetting those emissions to make the event carbon neutral by supporting energy efficiency, renewable ...
... As ... ... as other commercial real estate sectors struggle, investors continue to pour hundreds of millions ... new debt and $30 million in new equity from Prudential Real Estate Investors (PREI), ...
Cached Biology Technology:Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 2Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 3Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 4Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 5Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 6Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 7Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 8Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 9Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 10Anadys Pharmaceuticals Reports Second Quarter 2009 Financial Results and Program Highlights 11Biopolymers Symposium 2009 Teams with Carbonfund.org to Create a Zero-Carbon Event 2Millions Flowing into Medical Real Estate 2Millions Flowing into Medical Real Estate 3
(Date:2/19/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/kx9zp8/military ) ... Electro-Optical / Infrared Systems Market by Type, by ... to 2020" report to their offering. ... expected to reach $16.35 billion by 2020, to ... report segments the military electro-optical/infrared systems market on ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
(Date:2/10/2015)... -- Alere Inc. (NYSE: ALR), a global leader in ... quarter ended December 31, 2014. Namal ... said, "We made substantial progress in the fourth ... in rapid diagnostics and delivering against our financial ... early January enabled us to substantially reduce our ...
Breaking Biology News(10 mins):Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
... came from other planets. So concludes a major scientific article which ... Cosmology.com For thousands ... life. Surprisingly, most scientists and the Catholic Church are of the ... "organic soup." In the Judeo-Christian Bible, the ...
... Dental and tissue engineering researchers at Tufts University School of ... at Tufts have harnessed the pluripotency of human embryonic stem ... skin and the oral mucosa (the moist tissue that lines ... online in advance of print in Tissue Engineering Part ...
... scientists at Iowa State University,s Plant Sciences Institute has ... in plant genes much more efficient, practical and safe. ... associate scientist, and Jeffery Townsend, an assistant scientist, and ... have a huge impact on plant genetic work in ...
Cached Biology News:Life on Earth came from other planets 2Life on Earth came from other planets 3Life on Earth came from other planets 4Skin-like tissue developed from human embryonic stem cells 2Iowa State University researchers develop process for 'surgical' genetic changes 2Iowa State University researchers develop process for 'surgical' genetic changes 3
... In virtually every research laboratory, the ... of information accurately, inexpensively and in real ... compact lab analysis system includes the Luminex ... It utilizes xMAP technology which enables you ...
... Luminex 100 IS System is a compact analysis ... integrates lasers, optics, fluidics, a controller, advanced digital ... powerful, compact lab analysis system includes the Luminex ... it has a DMF file at the FDA, ...
... of amino acids and peptides produced ... It is recommended for laboratory media ... in antibiotics, toxins and enzyme productions. ... pH6.8 0.5 at 25 C, 2% ...
... Highly nutritious peptone, used ... production of bacterial toxins, ... of bacteria with high ... Haemophilus, Neisseria, Pasteurella, Salmonella ...
Biology Products: